An Effective Treatment for Recurrent and Acute Migraines

Designed with You in Mind


MigraPure Label.jpg

MIGRAPURE

The MigraPure products are the result of over 15 years of research and development including both in vitro and in vivo studies. This includes 4 clinical studies.

The studies were all conducted by world class headache specialists with research and analysis published in top tier medical journals.

The MigraPure products are patented for both the acute treatment of migraines and the prevention of migraines.

Efficacy and safety data for ages 6-60

Sublingual delivery provides fast efficient absorption. Avoids the degradation of the first pass effect caused by the stomach and liver. A little goes a long way!

 MigraPure is highly effective and very safe. Side effects profile similar to placebo.

All natural

Headache/Migraine is the third largest reason patients visit chiropractors, behind back pain and neck pain.

MigraPure products are available only through health professionals. Not available through retail stores.

MigraPure products provide great margins to add additional profits

NOW AVAILABLE!

 
 
MigraPureHLabel.jpg

MigraPure H

The MigraPureH hemp version provides the added benefits of reducing oxidative stress and anti- inflammatory activity.

The hemp used in MigraPureH is legally imported from Europe and is legal in all 50 states. It is broad a spectrum, certified for quality and provides additional cannabinoids, terpenes and flavonoids. It also adds additional omega-3 and omega-6 fatty acids to enhance the olive oil base.

COMING SOON!

Details We Want You to Know


There is a Need for An Effective Product

40.7% of 5,591 survey respondents had one or more unmet needs

51% of patients are dissatisfied overall with products they currently use

75% of patients say their product does not work fast enough

 

Many Existing Products Have Significant Side Effects

At least one common and painful side effect is listed on every recommended treatment- OTC or prescription 

some side effects are as debilitating as the condition itself

 

The U.S. Migraine Market

Approximately 20% of women and 10% of men suffer from migraine headaches

The primary age for sufferers is between 18 and 45 years

Those affected by migraines are 75% more likely to have an immediate family member who also suffer from migraines

57% of those affected by migraines rely on OTC treatments that are ineffective for acute migraines

FDA warnings for acetaminophen include severe liver damage and fatal skin reactions

OTC and Rx migraine formulations are associated with medication-overuse or rebound headaches

 

Who's Affected

Less than half of migraine sufferers have ever been medically diagnosed

Nine out of ten of the 37 million sinus headaches reported each year are actually migraines

Combat veterans have up to three times the migraine occurrence rate compared to the general populations

 

Migraine Headaches are the Most Costly Brain Disorder in the U.S. 

An estimated 50 million people suffer from migraine headaches

3% of sufferers will experience migraines 15 or more days per month - an average of 35 headaches per year

Which equates to 1.65 billion events per year

 

More Than Eight Million Children Suffer from Migraines

10% of the pediatric population suffer from migraines

Migraines often start before the age of 12

U.S. children miss approximately 12 days of school each month due to headache

Current Rx migraine medications are ineffective for pediatric migraines